1 / 1

Key Insights from Published RCTs on Therapeutics in LVV

Explore valuable findings and considerations from randomized controlled trials (RCTs) on therapeutics in LVV, excluding steroid dosing trials. Learn about trial design challenges in ANCA-associated and large-vessel vasculitis.

patience-kelly
Download Presentation

Key Insights from Published RCTs on Therapeutics in LVV

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Table 2 Published RCTs of therapeutics in LVV, excluding trials of steroid dosing alone Tarzi, R. M. et al. (2014) Issues in trial design for ANCA-associated and large-vessel vasculitis Nat. Rev. Rheumatol. doi:10.1038/nrrheum.2014.67

More Related